Up Next
Back to Show
PBS News Hour
Why FDA approval of sickle cell gene therapy is a ‘big deal’
Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.
Support Provided By
26:44
"PBS NewsHour" asks NATO’s Secretary General if the delayed U.S. aid to Ukraine is too late to make a difference.
56:45
A court rejects Trump's claim of immunity with major implications for his election interference case.
26:36
Why a record number of people across America are experiencing homelessness this holiday season.
24:44
How some cities are testing no-strings-attached payment programs as a way to help lower-income residents get a leg up.
56:45
Hunter Biden's plea deal unravels over concerns about whether future charges can be brought against the president's son.
56:45
This episode is the July 19, 2023 broadcast.
56:45
Floodwaters rage and dangerous heat waves grow worse, posing serious risks to millions of Americans.
56:44
NATO leaders kick off a multi-nation summit with Ukraine seeking a path to join the expanding alliance.
56:45
A federal judge limits the Biden administration's contact with social media companies over concerns about censorship and free speech.
The global surge in energy costs is impacting millions around the world.
26:45
With monkeypox cases on the rise, concerns grow over disparities in access to vaccines, testing and treatment.
56:41
President Biden asks Congress to suspend the federal gas tax temporarily as rising prices pinch Americans nationwide.